Literature DB >> 11435961

T cell and B cell tolerance to GALalpha1,3GAL-expressing heart xenografts is achieved in alpha1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism.

H Ohdan1, Y G Yang, K G Swenson, H Kitamura, M Sykes.   

Abstract

BACKGROUND: We have previously demonstrated that mixed xenogeneic chimerism and donor-specific T-cell tolerance can be induced in the rat-to-mouse species combination by using a relatively nontoxic, nonmyeloablative conditioning regimen. However, natural antibodies (NAbs) against Galalpha1,3Gal (Gal) pose an additional major barrier to pig-to-human vascularized xenograft acceptance.
METHODS: To determine whether the mixed chimerism approach could also overcome this humoral barrier, T cell-depleted rat (GalT+/+) bone marrow cells (BMC) were transplanted to alpha1,3-galactosyltransferase deficient (GalT-/-) mice conditioned with a nonmyeloablative regimen, consisting of transient T cell and natural killer (NK) cell depletion, 3 Gy whole body irradiation, and 7 Gy thymic irradiation.
RESULTS: By giving a high dose (180x106) of rat BMC, persistent mixed chimerism could be induced in GalT-/- mice, although the level of donor-type hematopoietic repopulation declined over time. Induction of mixed chimerism was associated with a rapid disappearance of anti-Gal and anti-rat NAb in the sera. Both anti-Gal Ab-producing cells and B cells with receptors recognizing Gal were undetectable in mixed chimeras, even when the chimerism levels declined, suggesting that a very low level of chimerism could effectively maintain B-cell tolerance to Gal, probably by clonal deletion and/or receptor editing. Mixed chimeras accepted subsequently transplanted donor-type rat hearts (>100 days) without immunosuppressive therapy, whereas delayed vascular and even hyperacute rejection of rat hearts occurred in conditioned control GalT-/- mice. Cellular rejection occurred by 5-6 days in conditioned control wild-type mice.
CONCLUSIONS: These findings demonstrate that induction of mixed chimerism with a nonmyeloablative regimen can prevent vascularized xenograft rejection by cellular and anti-Gal Ab-dependent pathways in GalT+/+-to-GalT-/- species combinations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435961     DOI: 10.1097/00007890-200106150-00009

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  17 in total

Review 1.  CD47 in xenograft rejection and tolerance induction.

Authors:  Yong-Guang Yang
Journal:  Xenotransplantation       Date:  2010 Jul-Aug       Impact factor: 3.907

Review 2.  Current progress in xenogeneic tolerance.

Authors:  Kazuhiko Yamada; Joseph Scalea
Journal:  Curr Opin Organ Transplant       Date:  2012-04       Impact factor: 2.640

3.  B-cell extrinsic CR1/CR2 promotes natural antibody production and tolerance induction of anti-alphaGAL-producing B-1 cells.

Authors:  Ichiro Shimizu; Toshiyasu Kawahara; Fabienne Haspot; Philip D Bardwell; Michael C Carroll; Megan Sykes
Journal:  Blood       Date:  2006-10-05       Impact factor: 22.113

Review 4.  IXA Honorary Member Lecture, 2017: The long and winding road to tolerance.

Authors:  Megan Sykes
Journal:  Xenotransplantation       Date:  2018-05       Impact factor: 3.907

Review 5.  Tolerance in xenotransplantation.

Authors:  Kazuhiko Yamada; Megan Sykes; David H Sachs
Journal:  Curr Opin Organ Transplant       Date:  2017-12       Impact factor: 2.640

6.  Innate and adaptive immune responses are tolerized in chimeras prepared with nonmyeloablative conditioning.

Authors:  Hong Xu; Ziqiang Zhu; Yiming Huang; Larry D Bozulic; Lala-Rukh Hussain; Jun Yan; Suzanne T Ildstad
Journal:  Transplantation       Date:  2012-03-15       Impact factor: 4.939

7.  Intra-bone bone marrow transplantation from hCD47 transgenic pigs to baboons prolongs chimerism to >60 days and promotes increased porcine lung transplant survival.

Authors:  Hironosuke Watanabe; Yuichi Ariyoshi; Thomas Pomposelli; Kazuhiro Takeuchi; Dilrukshi K Ekanayake-Alper; Lennan K Boyd; Scott J Arn; Hisashi Sahara; Akira Shimizu; David Ayares; Marc I Lorber; Megan Sykes; David H Sachs; Kazuhiko Yamada
Journal:  Xenotransplantation       Date:  2019-09-23       Impact factor: 3.907

Review 8.  Pancreatic islet xenotransplantation: barriers and prospects.

Authors:  Gina R Rayat; Ronald G Gill
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

Review 9.  Application of xenogeneic stem cells for induction of transplantation tolerance: present state and future directions.

Authors:  Yong-Guang Yang
Journal:  Springer Semin Immunopathol       Date:  2004-09-11

Review 10.  Xenotransplantation: immunological hurdles and progress toward tolerance.

Authors:  Adam Griesemer; Kazuhiko Yamada; Megan Sykes
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.